GLUMIP 2.0: SAS/IML Software for Planning Internal Pilots

by John A. Kairalla, Christopher S. Coffey, Keith E. Muller
Published 2008-09-01

The Association of the Metabolic Syndrome with PAI-1 and t-PA Levels

by Christopher S. Coffey, Folkert W. Asselbergs, Patricia R. Hebert, Hans L. Hillege, Qing Li, Jason H. Moore, Wiek H. van Gilst
Published 2011-01-01

Cardiovascular risk associated with interactions among polymorphisms in genes from the renin-angiotensin, bradykinin, and fibrinolytic systems.

by John P Bentley, Folkert W Asselbergs, Christopher S Coffey, Patricia R Hebert, Jason H Moore, Hans L Hillege, Wiek H van Gilst
Published 2010-09-01

Alterations in Lipoxygenase and Cyclooxygenase-2 Catalytic Activity and mRNA Expression in Prostate Carcinoma

by Scott B. Shappell, Suzanne Manning, William E. Boeglin, You-Fei Guan, Richard L. Roberts, Linda Davis, Sandra J. Olson, Gregory S. Jack, Christopher S. Coffey, Thomas M. Wheeler, Matthew D. Breyer, Alan R. Brash
Published 2001-01-01

Missing data in randomized clinical trials for weight loss: scope of the problem, state of the field, and performance of statistical methods.

by Mai A Elobeid, Miguel A Padilla, Theresa McVie, Olivia Thomas, David W Brock, Bret Musser, Kaifeng Lu, Christopher S Coffey, Renee A Desmond, Marie-Pierre St-Onge, Kishore M Gadde, Steven B Heymsfield, David B Allison
Published 2009-08-01

Cognition among individuals along a spectrum of increased risk for Parkinson's disease.

by Lana M Chahine, Liz Urbe, Chelsea Caspell-Garcia, Dag Aarsland, Roy Alcalay, Paolo Barone, David Burn, Alberto J Espay, Jamie L Hamilton, Keith A Hawkins, Shirley Lasch, James B Leverenz, Irene Litvan, Irene Richard, Andrew Siderowf, Christopher S Coffey, Tanya Simuni, Daniel Weintraub, Parkinson’s Progression Markers Initiative
Published 2018-01-01

Neuropsychiatric symptoms and cognitive abilities over the initial quinquennium of Parkinson disease

by Daniel Weintraub, Chelsea Caspell‐Garcia, Tanya Simuni, Hyunkeun R. Cho, Christopher S. Coffey, Dag Aarsland, Roy N. Alcalay, Matthew J. Barrett, Lana M. Chahine, Jamie Eberling, Alberto J. Espay, Jamie Hamilton, Keith A. Hawkins, James Leverenz, Irene Litvan, Irene Richard, Liana S. Rosenthal, Andrew Siderowf, Michele York, Parkinson’s Progression Markers Initiative
Published 2020-04-01

Recruitment & retention program for the NeuroNEXT SMA Biomarker Study: Super Babies for SMA!

by Amy Bartlett, Stephen J. Kolb, Allison Kingsley, Kathryn J. Swoboda, Sandra P. Reyna, Ai Sakonju, Basil T. Darras, Richard Shell, Nancy Kuntz, Diana Castro, Susan T. Iannaccone, Julie Parsons, Anne M. Connolly, Claudia A. Chiriboga, Craig McDonald, W. Bryan Burnette, Klaus Werner, Mathula Thangarajh, Perry B. Shieh, Erika Finanger, Christopher S. Coffey, Jon W. Yankey, Merit E. Cudkowicz, Michelle M. McGovern, D. Elizabeth McNeil, W. David Arnold, John T. Kissel
Published 2018-09-01